Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development Post published:December 22, 2020 Post category:Press Release
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing Post published:December 21, 2020 Post category:Press Release
Mydecine Innovations Group Engages ethica CRO as Contract Research Organization Partner for Phase 2A PTSD Clinical Trials Post published:December 21, 2020 Post category:Press Release
PharmaTher Signs LOI to Sell Psilocybin Program to Revive Therapeutics Post published:December 21, 2020 Post category:Press Release
Revive Therapeutics Announces LOI to Acquire PharmaTher’s Psilocybin Program Post published:December 21, 2020 Post category:Press Release
BetterLife Closes Acquisition of Second Generation Psychedelic Assets of Transcend Biodynamics LLC Post published:December 21, 2020 Post category:Press Release
Entheon Biomedical Announces Private Placement Post published:December 18, 2020 Post category:Press Release
Tryp Therapeutics Begins Trading on the Canadian Securities Exchange Post published:December 18, 2020 Post category:Press Release
Ehave, Inc. Issues CEO Letter to Stockholders, Reports on Significant Progress and Outlook for 2021 Post published:December 17, 2020 Post category:Press Release
MagicMed Industries Announces Closing of Upsized and Oversubscribed $8.1 Million Private Placement of Units Led by Gravitas Securities Due to Significant Investor Demand Post published:December 17, 2020 Post category:Press Release